Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer.

Mainini, Francesco; De Santis, Francesca; Fucà, Giovanni; Di Nicola, Massimo; Rivoltini, Licia; Eccles, Michael

Mainini, Francesco; De Santis, Francesca; Fucà, Giovanni; Di Nicola, Massimo; Rivoltini, Licia; Eccles, Michael.

Afiliação

Mainini F; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
De Santis F; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Fucà G; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Di Nicola M; Immunotherapy and Innovative Therapeutics Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Eccles M; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.

Cancers (Basel) ; 13(15)2021 Jul 27.

Article em En | MEDLINE | ID: mdl-34359665

Palavras-chave

PD-1; adoptive cell therapy; immune checkpoint; immunomodulation; immunotherapy; nanomedicine; nanoparticles; nanotechnology; nanovaccines; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google